Plain-English translation of NCT04183608 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ulcerative Colitis research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether a new approach to treatment with —including remote monitoring from home, regular testing, and patient education—works better than standard care for ulcerative colitis. The medication is an anti-inflammatory injection that helps calm the immune system when it's attacking your colon. The trial wants to see if staying closely connected to your care team between doctor visits helps you feel better and heal faster.
Standard ulcerative colitis care involves visiting your doctor every three months, which means treatment adjustments can only happen that often. This trial is testing whether checking in more frequently from home—through blood tests, stool tests, and direct contact with your care team—can help doctors catch problems earlier and adjust your treatment faster, leading to better outcomes.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to one of two groups. In the standard care group, you visit your doctor every three months for check-ups and treatment adjustments. In the monitored group, you also receive home testing kits to check your stool regularly, use a smartphone app to report how you're feeling, and receive education about managing your condition—allowing your doctors to adjust your treatment more frequently if needed. Either way, you'll have appointments over three years, with detailed check-ins at certain time points to measure how well you're healing.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
France